BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22864777)

  • 1. Clinical-pathological correlation of K-Ras mutation and ERK phosphorylation in colorectal cancer.
    Tai CJ; Chang CC; Jiang MC; Yeh CM; Su TC; Wu PR; Chen CJ; Yeh KT; Lin SH; Chen HC
    Pol J Pathol; 2012 Jun; 63(2):93-100. PubMed ID: 22864777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
    Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
    Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer.
    Tai CJ; Lee CH; Chen HC; Wang HK; Jiang MC; Su TC; Shen KH; Lin SH; Yeh CM; Chen CJ; Yeh KT; Chang CC
    Ann Diagn Pathol; 2013 Apr; 17(2):165-71. PubMed ID: 23183114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
    Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
    J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
    Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
    Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
    Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
    Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
    Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
    Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
    Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
    J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.
    Gulmann C; Sheehan KM; Conroy RM; Wulfkuhle JD; Espina V; Mullarkey MJ; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2009 Aug; 218(4):514-9. PubMed ID: 19396842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.
    Kraus MC; Linnemann U; Berger MR
    Oncol Rep; 2011 May; 25(5):1421-9. PubMed ID: 21369707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.
    Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
    Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
    Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
    Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
    Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.